TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)

Historical Holders from Q1 2014 to Q3 2025

Symbol
TAK on NYSE
CUSIP
874060205
Type / Class
Equity / SPONSORED ADS
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
77.8M
Holdings value
$1.2B
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
305
Number of buys
172
Number of sells
-101
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 168K $2.46M +$11.3K $14.64 12
2025 Q2 77.8M $1.2B +$107M $15.46 305
2025 Q1 71.1M $1.06B -$156K $14.87 299
2024 Q4 72M $954M -$55.4M $13.24 291
2024 Q3 71.6M $1.02B +$20.5M $14.22 296
2024 Q2 72.1M $941M -$86.5M $12.94 282
2024 Q1 78.2M $1.09B -$75.3M $13.89 310
2023 Q4 83.2M $1.19B +$44.6M $14.27 298
2023 Q3 80.2M $1.24B -$62.7M $15.47 305
2023 Q2 83.8M $1.32B -$49.9M $15.71 302
2023 Q1 81.6M $1.34B +$255M $16.48 288
2022 Q4 67.7M $1.06B +$60.4M $15.60 270
2022 Q3 63.3M $821M +$94.4M $12.97 250
2022 Q2 56.6M $795M +$69.1M $14.04 251
2022 Q1 55.7M $797M -$259M $14.32 257
2021 Q4 71.1M $971M -$283M $13.63 262
2021 Q3 91.7M $1.5B -$41.6M $16.38 269
2021 Q2 94.7M $1.59B -$224M $16.83 281
2021 Q1 107M $1.96B -$5.54M $18.26 294
2020 Q4 108M $1.97B +$47.7M $18.20 283
2020 Q3 107M $1.91B -$77.9M $17.84 290
2020 Q2 110M $1.98B -$82.8M $17.93 284
2020 Q1 115M $1.75B -$256M $15.18 279
2019 Q4 129M $2.55B -$263M $19.73 315
2019 Q3 141M $2.43B -$10.1M $17.20 287
2019 Q2 145M $2.57B -$492M $17.70 318
2019 Q1 177M $3.61B +$2.48B $20.37 357
2018 Q4 53.8M $908M +$834M $16.82 79
2018 Q3 2.92M $62.3M +$9.17M $21.37 14
2018 Q2 2.49M $52.1M +$10.8M $20.90 12
2018 Q1 1.88M $46M +$5.62M $24.55 8
2017 Q4 1.65M $47M +$7.83M $28.30 7
2017 Q3 1.38M $38.1M +$9.51M $27.54 6
2017 Q2 1.03M $26.3M +$3.29M $25.42 5
2017 Q1 904K $21.3M +$7.3M $23.63 5
2016 Q4 598K $12.4M +$280K $20.78 6
2016 Q3 584K $14M +$3.23M $23.88 4
2016 Q2 450K $9.68M -$5.84M $21.54 6
2016 Q1 721K $16.4M +$3.73M $22.82 7
2015 Q4 557K $14M +$8.51M $25.02 8
2015 Q3 232K $5.06M -$7.91M $21.88 8
2015 Q2 556K $13.5M +$636K $24.16 7
2015 Q1 530K $13.3M +$1.84M $25.00 8
2014 Q4 456K $9.48M -$83.6K $20.84 8
2014 Q3 460K $10M +$531K $21.75 8
2014 Q2 436K $10.1M -$6.9M $23.19 7
2014 Q1 726K $17.2M +$5.03M $23.75 9